The legal library gives you easy access to the FTC’s case information and other official legal, policy, and guidance documents.
Solar D. Skincare, LLC (Solar D sunscreen)
20170620: MPLX LP; Marathon Petroleum Corporation
T-Mobile USA, Inc.
As part of a $90 million proposed settlement, T-Mobile is refunding customers who were unfairly billed third-party charges by the company.
T-Mobile has been contacting all of its current and former crammed customers to let them know about the refund program and claims process. Customers can get more information about T-Mobile’s refund program at www.t-mobilerefund.com.
Valeant Pharmaceuticals International, Inc., In the Matter of
Valeant Pharmaceuticals, the parent of Bausch + Lomb, agreed to sell Paragon Holdings I, Inc. to settle charges that its May 2015 acquisition of Paragon reduced competition for the sale of FDA-approved buttons used for three types of gas permeable, or GP, lenses: orthokeratology lenses, worn to reshape the cornea; large-diameter scleral lenses, which cover the white of the eye and are used after eye surgery, for corneal transplants, and to treat eye disease; and general vision correction lenses. Valeant will sell Paragon in its entirety to a newly created entity, Paragon Companies LLC, headed by the former president of Paragon, Joe Sicari. Under the settlement, Paragon Companies also will acquire the assets of Pelican Products LLC – a contact lens packaging company that Valeant acquired after its purchase of Paragon – that is the only producer of FDA-approved vials used for shipping some GP lenses.
20170560: Gartner, Inc.; CEB Inc.
20170540: ArcLight Energy Partners Fund VI, L.P.; Lindsay Goldberg III AIV L.P.
20170581: Monomoy Capital Partners II, L.P.; Corinthian Equity Fund, L.P.
Cooperativa de Médicos Oftalmólogos de Puerto Rico, In the Matter of
OFTACOOP, a Puerto Rico ophthalmologist cooperative, has agreed to settle FTC charges that its actions harmed competition. The complaint charges that OFTACOOP – also known as Cooperativa de Médico Oftalmólogos de Puerto Rico – unlawfully orchestrated an agreement among competing ophthalmologists to refuse to deal with a health plan, MCS Advantage, Inc., and its network administrator, Eye Management of Puerto Rico, LLC. OFTACOOP’s concerted refusal to deal forced MCS to abandon its plan to engage Eye Management to create a lower-cost network of ophthalmologists. MCS was also forced to maintain its then-current reimbursement rates paid to ophthalmologists. According to the complaint, OFTACOOP restrained competition without any justification, in violation of federal antitrust law. The proposed consent order prohibits OFTACOOP from entering into or facilitating agreements between or among ophthalmologists (1) to refuse to deal, or threaten to refuse to deal, with any payor regarding any term, including price terms, or (2) not to deal individually with any payor, or not to deal with any payor other than through OFTACOOP. The order also prohibits information exchanges to facilitate any prohibited conduct, and it bars any attempts to engage in any prohibited conduct. OFTACOOP is also barred from encouraging, suggesting, advising, pressuring, inducing, or trying to induce anyone to engage in any prohibited conduct.